Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-09-10
1988-01-05
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546296, 546302, C07D21324, C07D21330, A61K 3144
Patent
active
047177268
ABSTRACT:
3,5-Dichloro-2,4-dimethoxy-6-(trichloromethyl)-pyridine, which can be prepared from 2,3,4,5-tetrachloro-6-(trichloromethyl)pyridine and an alkali metal methoxide, is an anticancer agent especially useful for the treatment of leukemias, lymphomas, mammary carcinomas, and ovarian sarcomas.
REFERENCES:
patent: 4190662 (1980-02-01), Fenstermacher et al.
Remers Antineoplastic Agents, pp. 70-76, Wiley-Interscience Pub. 1984.
NIH Publication No. 84-2635, pp. 111, V, 5, 15, 23, 27, 31, "In Vivo Cancer Models" 1976-1982 Pub. NCI Feb. 1984.
Osborne D. Wendell
Rotman Alan L.
The Dow Chemical Company
LandOfFree
3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine having an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine having an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine having an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-9281